Petrera Erina, Coto Celia E
Laboratory of Virology, Department of Biochemistry, School of Science, University of Buenos Aires, Buenos Aires, Argentina.
Virol J. 2006 Jun 13;3:45. doi: 10.1186/1743-422X-3-45.
Recent studies have shown that gamma interferon (IFN-gamma) synergizes with IFN-alpha/beta to inhibit herpes simplex virus type 1 (HSV-1) replication in vitro. Since IFN response represents an early host defense event against viral infection and the fact that treatment with meliacine, a plant antiviral, ameliorate the severity of the herpetic infection in female mice infected intravaginally with HSV-2, we wanted to investigate whether the administration of meliacine to HSV-2 infected mice could altered the homoestasis of IFNs host response. For this purpose we studied the effect of the compound 1-cinnamoyl-3,11-dihydroxymeliacarpin (CDM), which is the responsible for meliacine antiviral action, on the HSV-2 inhibition exerted by IFN alpha, IFN-gamma or their combination.
We have found that like HSV-1, IFN-gamma synergizes with IFN-alpha to inhibit HSV-2 replication in Vero cells. While treatment with IFN-alpha or IFN-gamma alone has weak antiviral action, HSV-2 plaque formation, viral replication and the onset of viral CPE in Vero cells are synergistically inhibited by interferon combination. In addition, CDM treatment contributes to protect cells from virus cytopathic effect and causes a strong inhibition of HSV-2 titer. Moreover, the presence of CDM for 2 h before IFN induction, during the 16 h induction period, only for 24 h after infection or during the complete IFN treatment period, reduces virus yields in an additive way without affecting IFN antiviral action.
The results reported here indicated that the presence of CDM did not alter the antiviral activity of IFN-alpha, IFN-gamma or the synergism exerted by their combination. As a result we can envision that the administration of CDM in vivo could not affect the biological activity of IFNs, which are so important mediators of the innate resistance to HSV-2 infection.
近期研究表明,γ干扰素(IFN-γ)与IFN-α/β协同作用可在体外抑制单纯疱疹病毒1型(HSV-1)复制。由于IFN反应是宿主针对病毒感染的早期防御事件,且植物抗病毒药美里辛治疗可减轻经阴道感染HSV-2的雌性小鼠疱疹感染的严重程度,我们想研究给感染HSV-2的小鼠施用美里辛是否会改变IFN宿主反应的稳态。为此,我们研究了负责美里辛抗病毒作用的化合物1-肉桂酰基-3,11-二羟基吴茱萸次碱(CDM)对IFN-α、IFN-γ或它们的组合所发挥的HSV-2抑制作用的影响。
我们发现,与HSV-1一样,IFN-γ与IFN-α协同作用可在Vero细胞中抑制HSV-2复制。虽然单独用IFN-α或IFN-γ治疗具有较弱的抗病毒作用,但IFN组合可协同抑制Vero细胞中HSV-2蚀斑形成、病毒复制及病毒致细胞病变效应(CPE)的发生。此外,CDM治疗有助于保护细胞免受病毒细胞病变效应影响,并强烈抑制HSV-2滴度。而且,在IFN诱导前2小时、诱导16小时期间、感染后仅24小时或整个IFN治疗期间存在CDM,可累加降低病毒产量,而不影响IFN的抗病毒作用。
此处报道的结果表明,CDM的存在未改变IFN-α、IFN-γ的抗病毒活性或它们组合所发挥的协同作用。因此我们可以设想,在体内施用CDM不会影响IFN的生物学活性,而IFN是对HSV-2感染先天抵抗的重要介质。